The need for efficient long-term neuroleptic treatment in schizophrenic patients and the place of long acting injectable antipsychotics

被引：0
作者：
Hans-Jurgen Möller
机构：
[1] Ludwig-Maximilians University,Psychiatric Department
来源：
Annals of General Psychiatry | / 9卷 / Suppl 1期
关键词：
Schizophrenia; Risperidone; Tardive Dyskinesia; Superior Efficacy; Neuroleptic Treatment;
D O I：
10.1186/1744-859X-9-S1-S68
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 4 条
[1]  
Möller HJ(2004)Course and long-term treatment of schizophrenic psychoses Pharmacopsychiatry 37 126-35
[2]  
Möller HJ(2006)Long-acting risperidone: focus on safety Clin Ther 28 633-51
[3]  
Möller HJ(2007)Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives Drugs 67 1541-66
[4]  
Möller HJ(2008)Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond Eur Arch Psychiatry Clin Neurosci 258 48-73
1